Papillary Thyroid Carcinoma Treated with Radiofrequency Ablation in a Patient with Hypertrophic Cardiomyopathy: A Case Report
Korean Journal of Radiology 2016³â 17±Ç 4È£ p.558 ~ p.561
(Sun Jian Yi) - Zhejiang University Medical College First Affiliated Hospital Department of Gastrointestinal and Thyroid Surgery
(Liu Xiao Sun) - Zhejiang University Medical College First Affiliated Hospital Department of Gastrointestinal and Thyroid Surgery
(Zhang Qing) - Zhejiang University Medical College First Affiliated Hospital Department of Gastrointestinal and Thyroid Surgery
(Hong Yan Yun) - Zhejiang University Medical College First Affiliated Hospital Department of Gastrointestinal and Thyroid Surgery
(Song Bin) - Zhejiang University Medical College First Affiliated Hospital Department of Gastrointestinal and Thyroid Surgery
(Teng Xiao Dong) - Zhejiang University Medical College First Affiliated Hospital Department of Pathology
(Yu Ji Ren) - Zhejiang University Medical College First Affiliated Hospital Department of Gastrointestinal and Thyroid Surgery
Abstract
Standard therapy has not been established for thyroid cancer when a thyroidectomy is contraindicated due to systemic disease. Herein, we reported a patient who had hypertrophic cardiomyopathy and papillary thyroid carcinoma treated by radiofrequency ablation because of inability to tolerate a thyroidectomy. Radiofrequency ablation can be used to treat thyroid cancer when surgery is not feasible, although the long-term outcome needs further observation.
Å°¿öµå
Papillary thyroid carcinoma, Hypertrophic cardiomyopathy, Radiofrequency catheter ablation
KMID :
0880420160170040558
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
This is the first reported case of PTC with hypertrophic cardiomyopathy treated with RFA. Radiofrequency ablation can be used to treat thyroid cancer when surgery is not feasible, although the long-term outcome needs further observation.